Social Determinants of Health and their Impact on COVID-19

Immunological and Autoimmune Disorders

The Evolved Gene Therapy for Hemophilia

Hemophilia is an inherited rare disorder where blood doesn’t clot in the regular way because the person affected doesn’t make enough blood-clotting proteins (clotting factors). Without these factor...

Nov 08, 2021

iga-nephropathy-treatment-market-size-share-trends-growth-cagr-companies-analysis
IgA Nephropathy – Navigating the Emerging Therapies and Key Companies in the Therapeutics Domain

IgA Nephropathy (IgAN), also called Berger’s disease, is an autoimmune rare disease affecting the kidneys. It impairs blood filtration in the kidneys' tiny blood channels. An aberrant protein destroys the filtering unit (glomerulus) inside the kidneys, causing IgA Nephropathy. It is estimated that 20–40% of persons...

Find More
medtech-news-for-hologic-luminopia-histosonics-phillips-polynovo
Hologic to acquire Bolder Surgical; Breakthrough Device Designation to Biological Dynamics; Luminopia declares FDA approval; HistoSonics secures Breakthrough Device Designation; Phillips-Medisize expands worldwide; PolyNovo launches NovoSorb BTM tech

Hologic to acquire Bolder Surgical for USD160 Million, expanding its Surgical Franchise  On October 14, 2021, Hologic, Inc., a global player in women's health, signed a definitive agreement to acquire Bolder Surgical. This US-based company offers advanced energy vessel sealing surgical devices for approxima...

Find More
recent-biotech-pharma-news-for-brickell-bms-amydis-gensight-cybrexa
Brickell to Submit New Drug Application to FDA; Twin Health Raises $140M; BMS’ Deucravacitinib; Lando Biopharma’s LABP-104 gets Approval; NIH Grant of $ 3 M to Amydis; FDA Grant to GenSight’ GS030

Brickell Plans to Submit New Drug Application to FDA for gel Brickell Biotech will request the FDA in mid-2022 to approve its gel for excessive underarm sweating after decreasing sweat production and disease severity in two pivotal trials.  The gel achieved statistical significance in lessening the sever...

Find More

More Views & Analysis

medtech-news-updates-for-iotamotion-recor-natera-boston-scientific
Amber Implants VCFix spinal system; iotaMotion’s iotaSOFT Insertion System; Boston Scientific acquires Baylis; ReCor’s Paradise Ultrasound Renal Denervation; Boston Scientific’s Ranger Drug-Coated Balloon; Natera’s Prospera

Amber Implants VCFix® spinal system obtains US FDA Breakthrough designation  On October 05, 2021, the US Food and Drug Administration (FDA) granted the Breakthrough Device Designation to VCFix® spinal system, a next-generation spinal implant for spinal injuries developed by Amber Implants, a Netherlands-bas...

Find More

global-nutraceuticals-market-cagr-trends-growth-size-share-products-benefits-drawbacks-side-effects
Analyzing the Key Opportunities & Challenges in the Nutraceuticals Market

Nutraceuticals often referred to as phytochemicals or functional food, are a group of products used both as nutrition for general well-being or as a medicine to control symptoms. These products are helpful in maintaining body growth, improving health, delaying the aging process, physiological balance,  increas...

Find More

myasthenia-gravis-treatment-market-growth-size-therapies-forecast-and-key-companies
Exploring the Market Potential of the Upcoming Therapies for the Myasthenia Gravis

Myasthenia Gravis is an autoimmune disease that causes muscle weakness and fatigue. It occurs when the communication between nerve cells and muscles is disrupted. This impairment prevents critical muscle contractions from occurring, resulting in muscle weakness. This disease is associated with antibodies directed a...

Find More

systemic-lupus-erythematosus-market-trends-growth-size-share-cagr-therapies-therapy-drugs-therapeutics-treatments
Systemic Lupus Erythematosus Treatment Market: How the Leading Companies are Countering the Rising Prevalence?

Systemic Lupus Erythematosus is a chronic inflammatory disease that affects connective tissues such as cartilage and blood vessel lining, which provide strength and flexibility to body structures. Systemic Lupus Erythematosus affects multiple organs and structures, including the skin, joints, kidneys, lungs, centra...

Find More

recent-pharma-news-updates-for-hebabiz-pfizer-astrazeneca-bms-masimo
AstraZeneca’s Ultomiris; HebaBiz’s Siroquine; Pfizer’s XELJANZ; Bristol Myers Squibb’s Opdivo; and Masimo’s PVi

AstraZeneca's Newly Occupied Alexion Hits Rock Bottom After Ultomiris (Ravulizumab) Fails to Show Efficacy in Patients with Amyotrophic Lateral Sclerosis AstraZeneca's 39 billion USD complete acquisition of Alexion took over just a few months back. Unpleasant news strike hard for their first deal in the rare neu...

Find More

pharma-news-and-updates-for-nanox-takeda-visus-lqt-therapeutics
LQTT secures $19M; Nanox acquires Zebra Medical Vision; Takeda leads IBD drug; Visus raises $20M

LQT Therapeutics secures USD 19 Million to tackle heart diseases with Sanofi compounds LQT Therapeutics intends to tackle debilitating heart arrhythmias with limited interventions, and investors are planting a seed in the biotech's heart with USD 19 million.  The two-year-old Canadian biotech will utiliz...

Find More

Soft Tissue Sarcoma (STS) tumors constitute 1% of all the malignancies. These are rare neoplasms tha.....

Find More

Cocaine Use Disorder (CUD) is characterized as a substance use disorder in which biological, psychol.....

Find More

With its innovative approach, chimeric antigen receptor T cell therapy created a new dawn in the age.....

Find More

A complex genetic condition, Prader-Willi syndrome (PWS) is a result of the loss of the functioning .....

Find More

It was assumed initially that Alzheimer’s Disease was a rare condition, but now it is considered t.....

Find More

HIV-associated lipodystrophy (HAL), is a condition characterized by the redistribution of adipose ti.....

Find More